20(S)-ginsenoside Rg3-induced apoptosis in HT-29 colon cancer cells is associated with AMPK signaling pathway

Molecular Medicine Reports

Volumn 3, Issue 5, 2010, Pages 825-831

  Yuan, Hai Dan ^a   Quan, Hai Yan ^a   Zhang, Ya ^a   Kim, Sung Hoon ^a   Chung, Sung Hyun ^a  

^a Kyung Hee University   (South Korea)

Author keywords

20(S) ginsenoside Rg3; AMP activated protein kinase; Apoptosis; HT 29 colon cancer cell; Panax ginseng

Indexed keywords

20 GINSENOSIDE RG3; ADENYLATE KINASE; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 9; CYTOCHROME C; ENZYME INHIBITOR; GINSENOSIDE RG 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; STO 609; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER CELL; CELL PROLIFERATION; CELL STRUCTURE; COLON CANCER; DNA FRAGMENTATION; DOWN REGULATION; HUMAN; HUMAN CELL; UPREGULATION;

PANAX GINSENG;

EID: 78049512903     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2010.328     Document Type: Article

References (34)

1. Wang .IB, Qi LL, Zheng SD and Wu TX: Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells. J Zhejiang Univ Sci B 10: 93-102, 2009.
2. Lee JH, Yang HS, Park KW, Kim JY, Lee MK, Jeong IY, Shim KH, Kim YS, Yamada K and Seo KI: Mechanisms of thiosulfinates from Allium tuberosum L.-induced apoptosis in HT-29 human colon cancer cells. Toxicol Lett 188: 142-147, 2009.
3. Kosmider S and Lipton L: Adjuvant therapies for colorectal cancer. World J Gastroenterol 13: 3799-3805, 2007.
4. Monga DK and O'Connell MJ: Surgical adjuvant therapy for colorectal cancer: current approaches and future directions. Ann Surg Oncol 13: 1021-1034, 2006. (Pubitemid 44337961)
5. Li WJ, Nie SP, Yu Q and Xie MY: (-)-Epigallocatechin-3-gallate induces apoptosis of human hepatoma cells by mitochondrial pathways related to reactive oxygen species. J Agric Food Chem 57: 6685-6691, 2009.
6. Yoshimoto M, Yahara S, Okuno S, Islam MS, Ishiguro K and Yamakawa O: Antimutagenicity of mono-, di-, and tricaffeoylquinic acid derivatives isolated from sweetpotato (Ipomoea batatas L.) leaf. Biosci Biotechnol Biochem 66: 2336-2341, 2002.
7. Ang-Lee MK, Moss J and Yuan CY: Herbal medicines and perioperative care. JAMA 286: 208-216, 2001.
8. Yun SN, Ko SK, Lee KH and Chung SH: Vinegar-processed ginseng radix improves metabolic syndrome induced by a high fat diet in ICR mice. Arch Pharm Res 30: 587-595, 2007.
9. Wang W, Zhao Y, Rayburn ER, Hill DL, Wang H and Zhang R: In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng. Cancer Chemother Pharmacol 59: 589-601, 2006.
10. Koo HN, Jeong HJ, Choi IY, An HJ, Moon PD, Kim SJ, Jee SY, Urn JY, Hong SH, Shin SS, Yang DC, Seo YS and Kim HM: Mountain-grown ginseng induces apoptosis in HL-60 cells and its mechanism have little relation with TNF-alpha production. Am J Chin Med 35: 169-182, 2007.
11. Kim WY, Kim JM, Han SB, Lee SK, Kim ND, Park MK, Kim CK and Park JH: Steaming of ginseng at high temperature enhances biological activity. J Nat Prod 63: 1702-1704, 2006.
12. Wang CZ, Aung HH, Ni M, Wu JA, Tong R, Wicks S, He TC and Yuan CS: Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Med 73: 669-674, 2007.
13. Keum YS, Han SS, Chun KS, Park KK, Park JH, Lee SK and Surh YJ: Inhibitory effects of the ginsenoside Rg3 on phorbol ester-induced cyclooxygenase-2 expression, NF-kappaB activation and tumor promotion. Mutat Res 523: 75-85, 2003.
14. Iishi H, Tatsuta M, Baba M, Uehara H, Nakaizumi A, Shinkai K, Akedo H, Funai H, Ishiguro S and Kitagawa I: Inhibition by ginsenoside Rg3 of bombesin-enhanced peritoneal metastasis of intestinal adenocarcinomas induced by azoxymethane in Wistar rats. Clin Exp Metastasis 15: 603-611, 1997.
15. Lee SY, Kim GT, Roh SH, Song JS, Kim HJ, Hong SS, Kwon SW and Park JH: Proteomic analysis of the anti-cancer effect of 20S-ginsenoside Rg3 in human colon cancer cell lines. Biosci Biotechnol Biochem 73: 811-816, 2009.
16. Lee YK, Park SY, Kim YM, Lee WS and Park OJ: AMP kinase/cyclooxygenase-2 pathway regulates proliferation and apoptosis of cancer cells treated with quercetin. Exp Mol Med 41: 201-207, 2009.
17. Huang CH, Tsai SJ, Wang YJ, Pan MH, Kao JY and Way TD: EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells. Mol Nutr Food Res 53: 1156-1165, 2009.
18. Hardie DG: New roles for the LKB1→AMPK pathway. Curr Opin Cell Biol 17: 167-173, 2005.
19. Su RY, Chao Y, Chen TY, Huang DY and Lin WW: 5-Aminoimidazole-4- carboxamide riboside sensitizes TRAIL- and TNF{alpha}-induced cytotoxicity in colon cancer cells through AMP-activated protein kinase signaling. Mol Cancer Ther 6: 1562-1571, 2007.
20. Shin SM, Cho IJ and Kim SG: Resveratrol protects mitochondria against oxidative stress through AMPK-mediated GSK3{beta} inhibition downstream of poly (ADP-ribose) polymerase-LKB1 pathway. Mol Pharmacol 76: 884-895, 2009.
21. Sai K, Yang D, Yamamoto H, Fujikawa H, Yamamoto S, Nagata T, Saito M, Yamamura T and Nishizaki T: A(1) adenosine receptor signal and AMPK involving caspase-9/-3 activation are responsible for adenosine-induced RCR-1 astrocytoma cell death. Neurotoxicology 27: 458-467, 2006. (Pubitemid 43867776)
22. Mochizuki M, Yoo YC, Matsuzawa K, Sato K, Saiki I, Tono-oka S, Samukawa K and Azuma I: Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20(R)- and 20(S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull 18: 1197-1202, 1995.
23. Shinkai K, Akedo H, Mukai M, Imamura F, Isoai A, Kobayashi M and Kitagawa I: Inhibition of in vitro tumor cell invasion by ginsenoside Rg3. Jpn J Cancer Res 87: 357-362, 1996. (Pubitemid 26147848)
24. 2+ influx and caspase-8 dependent pathways. Food Chem Toxicol 46: 3486-3492, 2008.
25. Kim SS, Won SJ, Kim NJ, Yoo JK, Bae K and Lee KT: 3-Oxoolean-12-en-27-oic acid isolated from Aceriphyllum rossii induces caspase-8-dependent apoptosis in human promyelocytic leukemia HL-60 cells. Biol Pharm Bull 32: 91-98, 2009.
26. Yan Y, Su X, Liang Y, Zhang J, Shi C, Lu Y, GU L and Fu L: Emodin azide methyl anthraquinone derivative triggers mitochondrial-dependent cell apoptosis involving in caspase-8-mediated Bid cleavage. Mol Cancer Ther 7: 1688-1697, 2008.
27. Mancini F, Di Conza G, Pellegrino M, et al. MDM4 (MDMX) localizes at the mitochondria and facilitates the p53-mediated intrinsic-apoptotic pathway. EMBO J 28: 1926-1939, 2009.
28. Bourgarel-Rey V, Savry A, Hua G, Carré M, Bressin C, Chacon C, Imbert J, Braguer D and Barra Y: Transcriptional down-regulation of Bcl-2 by vinorelbine: identification of a novel binding site of p53 on Bcl-2 promoter. Biochem Pharmacol 78: 1148-1156, 2009.
29. Hay N: The Akt-mTOR tango and its relevance to cancer. Cancer Cell 8: 179-183, 2005
30. Webler AC, Michaelis UR, Popp R, Barbosa-Sicard E, Murugan A, Falck JR, Fisslthaler B and Fleming I: Epoxyeicosatrienoic acids are part of the VEGF-activated signaling cascade leading to angiogenesis. Am J Physiol Cell Physiol 295: C1292-C1301, 2008.
31. Youn JY, Wang T and Cai H: An ezrin/calpain/PI3K/AMPK/eNOSsll79 signaling cascade mediating VEGF-dependent endothelial nitric oxide production. Circ Res 104: 50-59, 2009.
32. Hwang JT, Ha J, Park IJ, Lee SK, Baik HW, Kim YM and Park OJ: Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway. Cancer Lett 247: 115-121, 2007
33. 2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J Biol Chem 280: 29060-29066, 2005
34. Lage R, Diéguez C, Vidal-Puig A and López M: AMPK: a metabolic gauge regulating whole-body energy homeostasis. Trends Mol Med 14: 539-549, 2008.